JNK is a novel regulator of intercellular adhesion

Tissue Barriers

Volumn 1, Issue 5, 2013, Pages

  You, Hui ^a   Lei, Pedro ^a   Andreadis, Stelios T ^a,b,c  

^a the State University of New York   (United States)

^b University at Buffalo The State University of New York   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Adherens junction; Cell cell adhesion; Intercellular signaling; JNK; Substrate stiffness

Indexed keywords

ANTHRA [1, 9 CD] PYRAZOL 6 (2H) ONE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BETA CATENIN; CLAUDIN; CONNEXIN 43; FOCAL ADHESION KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN ZO1; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; UVOMORULIN;

APOPTOSIS; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; FOCAL ADHESION; GAP JUNCTION; HUMAN; METASTASIS; NONHUMAN; PROTEIN FUNCTION; REVIEW; TIGHT JUNCTION; WOUND HEALING;

EID: 84949555454     PISSN: 21688362     EISSN: 21688370     Source Type: Journal    
DOI: 10.4161/tisb.26845     Document Type: Review

References (126)

1. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000; 103:239-52. PMID:11057897 http://dx.doi.org/10.1016/S0092-8674(00)00116-1
2. Weston CR, Davis RJ. The JNK signal transduction pathway. Curr Opin Genet Dev 2002; 12:14-21. PMID:11790549 http://dx.doi.org/10.1016/S0959-437X(01)00258-1
3. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994; 369:156-60. PMID:8177321 http://dx.doi.org/10.1038/369156a0
4. Han SI, Ha KS, Kang KI, Kim HD, Kang HS. Heat shock-induced actin polymerization, SAPK/JNK activation, and heat-shock protein expression are mediated by genistein-sensitive tyrosine kinase(s) in K562 cells. Cell Biol Int 2000; 24:447-57. PMID:10875892 http://dx.doi.org/10.1006/cbir.2000.0512
5. Huangfu WC, Omori E, Akira S, Matsumoto K, Ninomiya-Tsuji J. Osmotic stress activates the TAK1-JNK pathway while blocking TAK1-mediated NF-kappaB activation: TAO2 regulates TAK1 pathways. J Biol Chem 2006; 281:28802-10. PMID:16893890 http://dx.doi.org/10.1074/jbc.M603627200
6. Devary Y, Gottlieb RA, Lau LF, Karin M. Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol Cell Biol 1991; 11:2804-11. PMID:1901948
7. Fanger GR, Gerwins P, Widmann C, Jarpe MB, Johnson GL. MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases? Curr Opin Genet Dev 1997; 7:67-74. PMID:9024636 http://dx.doi.org/10.1016/S0959-437X(97)80111-6
8. Hu YL, Li S, Shyy JY, Chien S. Sustained JNK activation induces endothelial apoptosis: studies with colchicine and shear stress. Am J Physiol 1999; 277:H1593-9. PMID:10516199
9. Yu C, Minemoto Y, Zhang J, Liu J, Tang F, Bui TN, Xiang J, Lin A. JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD. Mol Cell 2004; 13:329-40. PMID:14967141 http://dx.doi.org/10.1016/S1097-2765(04)00028-0
10. Sabapathy K, Hochedlinger K, Nam SY, Bauer A, Karin M, Wagner EF. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol Cell 2004; 15:713-25. PMID:15350216 http://dx.doi.org/10.1016/j. molcel.2004.08.028
11. Leppä S, Bohmann D. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. Oncogene 1999; 18:6158-62. PMID:10557107 http://dx.doi.org/10.1038/sj.onc.1203173
12. Lee MH, Koria P, Qu J, Andreadis ST. JNK phosphorylates beta-catenin and regulates adherens junctions. FASEB J 2009; 23:3874-83. PMID:19667122 http://dx.doi.org/10.1096/fj.08-117804
13. Yan J, Kong W, Zhang Q, Beyer EC, Walcott G, Fast VG, Ai X. c-Jun N-terminal kinase activation contributes to reduced connexin43 and development of atrial arrhythmias. Cardiovasc Res 2013; 97:589-97. PMID:23241357 http://dx.doi.org/10.1093/cvr/cvs366
14. Carrozzino F, Pugnale P, Féraille E, Montesano R. Inhibition of basal p38 or JNK activity enhances epithelial barrier function through differential modulation of claudin expression. Am J Physiol Cell Physiol 2009; 297:C775-87. PMID:19605737 http://dx.doi.org/10.1152/ajpcell.00084.2009
15. Xia Y, Karin M. The control of cell motility and epithelial morphogenesis by Jun kinases. Trends Cell Biol 2004; 14:94-101. PMID:15102441 http://dx.doi.org/10.1016/j.tcb.2003.12.005
16. Rämet M, Lanot R, Zachary D, Manfruelli P. JNK signaling pathway is required for efficient wound healing in Drosophila. Dev Biol 2002; 241:145-56. PMID:11784101 http://dx.doi.org/10.1006/dbio.2001.0502
17. Pedram A, Razandi M, Levin ER. Natriuretic peptides suppress vascular endothelial cell growth factor signaling to angiogenesis. Endocrinology 2001; 142:1578-86. PMID:11250939 http://dx.doi.org/10.1210/en.142.4.1578
18. Igaki T, Pagliarini RA, Xu T. Loss of cell polarity drives tumor growth and invasion through JNK activation in Drosophila. Curr Biol 2006; 16:1139-46. PMID:16753569 http://dx.doi.org/10.1016/j. cub.2006.04.042
19. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Dérijard B, Davis RJ. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 1996; 15:2760-70. PMID:8654373
20. Manning AM, Davis RJ. Targeting JNK for therapeutic benefit: from junk to gold? Nat Rev Drug Discov 2003; 2:554-65. PMID:12815381 http://dx.doi.org/10.1038/nrd1132
21. Bode AM, Dong Z. The functional contrariety of JNK. Mol Carcinog 2007; 46:591-8. PMID:17538955 http://dx.doi.org/10.1002/mc.20348
22. Morrison DK, Davis RJ. Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu Rev Cell Dev Biol 2003; 19:91-118. PMID:14570565 http://dx.doi.org/10.1146/annurev.cellbio.19.111401.091942
23. Lei K, Davis RJ. JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci U S A 2003; 100:2432-7. PMID:12591950 http://dx.doi.org/10.1073/pnas.0438011100
24. Xu P, Davis RJ. c-Jun NH2-terminal kinase is required for lineage-specific differentiation but not stem cell self-renewal. Mol Cell Biol 2010; 30:1329-40. PMID:20065035 http://dx.doi.org/10.1128/MCB.00795-09
25. Gazel A, Banno T, Walsh R, Blumenberg M. Inhibition of JNK promotes differentiation of epidermal keratinocytes. J Biol Chem 2006; 281:20530-41. PMID:16648634 http://dx.doi.org/10.1074/jbc.M602712200
26. Raitano AB, Halpern JR, Hambuch TM, Sawyers CL. The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation. Proc Natl Acad Sci U S A 1995; 92:11746-50. PMID:8524841 http://dx.doi.org/10.1073/pnas.92.25.11746
27. Kennedy NJ, Sluss HK, Jones SN, Bar-Sagi D, Flavell RA, Davis RJ. Suppression of Ras-stimulated transformation by the JNK signal transduction pathway. Genes Dev 2003; 17:629-37. PMID:12629045 http://dx.doi.org/10.1101/gad.1062903
28. Das M, Garlick DS, Greiner DL, Davis RJ. The role of JNK in the development of hepatocellular carcinoma. Genes Dev 2011; 25:634-45. PMID:21406557 http://dx.doi.org/10.1101/gad.1989311
29. Ventura JJ, Hübner A, Zhang C, Flavell RA, Shokat KM, Davis RJ. Chemical genetic analysis of the time course of signal transduction by JNK. Mol Cell 2006; 21:701-10. PMID:16507367 http://dx.doi.org/10.1016/j.molcel.2006.01.018
30. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996; 84:345-57. PMID:8608588 http://dx.doi.org/10.1016/S0092-8674(00)81279-9
31. Drees F, Pokutta S, Yamada S, Nelson WJ, Weis WI. Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly. Cell 2005; 123:903-15. PMID:16325583 http://dx.doi.org/10.1016/j.cell.2005.09.021
32. Lickert H, Bauer A, Kemler R, Stappert J. Casein kinase II phosphorylation of E-cadherin increases E-cadherin/beta-catenin interaction and strengthens cell-cell adhesion. J Biol Chem 2000; 275:5090-5. PMID:10671552 http://dx.doi.org/10.1074/jbc.275.7.5090
33. Behrens J, Vakaet L, Friis R, Winterhager E, Van Roy F, Mareel MM, Birchmeier W. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol 1993; 120:757-66. PMID:8425900 http://dx.doi.org/10.1083/jcb.120.3.757
34. Sadot E, Conacci-Sorrell M, Zhurinsky J, Shnizer D, Lando Z, Zharhary D, Kam Z, Ben-Ze'ev A, Geiger B. Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells. J Cell Sci 2002; 115:2771-80. PMID:12077367
35. Lee MH, Padmashali R, Koria P, Andreadis ST. JNK regulates binding of alpha-catenin to adherens junctions and cell-cell adhesion. FASEB J 2011; 25:613-23. PMID:21030692 http://dx.doi.org/10.1096/fj.10-161380
36. Naydenov NG, Hopkins AM, Ivanov AI. c-Jun N-terminal kinase mediates disassembly of apical junctions in model intestinal epithelia. Cell Cycle 2009; 8:2110-21. PMID:19502798 http://dx.doi.org/10.4161/cc.8.13.8928
37. You H, Padmashali RM, Ranganathan A, Lei P, Girnius N, Davis RJ, Andreadis ST. JNK regulates compliance-induced adherens junctions formation in epithelial cells and tissues. J Cell Sci 2013; 126:2718-29. PMID:23591817 http://dx.doi.org/10.1242/jcs.122903
38. Tsai J, Kam L. Rigidity-dependent cross talk between integrin and cadherin signaling. Biophys J 2009; 96:L39-41. PMID:19289031 http://dx.doi.org/10.1016/j.bpj.2009.01.005
39. Yamazaki Y, Okawa K, Yano T, Tsukita S, Tsukita S. Optimized proteomic analysis on gels of cell-cell adhering junctional membrane proteins. Biochemistry 2008; 47:5378-86. PMID:18416558 http://dx.doi.org/10.1021/bi8002567
40. Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 2004; 286:C1213-28. PMID:15151915 http://dx.doi.org/10.1152/ajpcell.00558.2003
41. Anderson JM, Van Itallie CM. Physiology and function of the tight junction. Cold Spring Harb Perspect Biol 2009; 1:a002584. PMID:20066090 http://dx.doi.org/10.1101/cshperspect.a002584
42. Andreeva AY, Krause E, Müller EC, Blasig IE, Utepbergenov DI. Protein kinase C regulates the phosphorylation and cellular localization of occludin. J Biol Chem 2001; 276:38480-6. PMID:11502742 http://dx.doi.org/10.1074/jbc.M104923200
43. Banan A, Zhang LJ, Shaikh M, Fields JZ, Choudhary S, Forsyth CB, Farhadi A, Keshavarzian A. theta Isoform of protein kinase C alters barrier function in intestinal epithelium through modulation of distinct claudin isotypes: a novel mechanism for regulation of permeability. J Pharmacol Exp Ther 2005; 313:962-82. PMID:15900076 http://dx.doi.org/10.1124/jpet.105.083428
44. D'Souza T, Agarwal R, Morin PJ. Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells. J Biol Chem 2005; 280:26233-40. PMID:15905176 http://dx.doi.org/10.1074/jbc.M502003200
45. Furuse M, Itoh M, Hirase T, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S. Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J Cell Biol 1994; 127:1617-26. PMID:7798316 http://dx.doi.org/10.1083/jcb.127.6.1617
46. Itoh M, Furuse M, Morita K, Kubota K, Saitou M, Tsukita S. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol 1999; 147:1351-63. PMID:10601346 http://dx.doi.org/10.1083/jcb.147.6.1351
47. Ando-Akatsuka Y, Yonemura S, Itoh M, Furuse M, Tsukita S. Differential behavior of E-cadherin and occludin in their colocalization with ZO-1 during the establishment of epithelial cell polarity. J Cell Physiol 1999; 179:115-25. PMID:10199550 http://dx.doi.org/10.1002/(S ICI)1097-4652(199905)179:2115::AID-JCP13.0.CO;2-T
48. Itoh M, Nagafuchi A, Moroi S, Tsukita S. Involvement of ZO-1 in cadherin-based cell adhesion through its direct binding to alpha catenin and actin filaments. J Cell Biol 1997; 138:181-92. PMID:9214391 http://dx.doi.org/10.1083/jcb.138.1.181
49. Barker RJ, Price RL, Gourdie RG. Increased association of ZO-1 with connexin43 during remodeling of cardiac gap junctions. Circ Res 2002; 90:317-24. PMID:11861421 http://dx.doi.org/10.1161/hh0302.104471
50. Kausalya PJ, Reichert M, Hunziker W. Connexin45 directly binds to ZO-1 and localizes to the tight junction region in epithelial MDCK cells. FEBS Lett 2001; 505:92-6. PMID:11557048 http://dx.doi.org/10.1016/S0014-5793(01)02786-7
51. Wittchen ES, Haskins J, Stevenson BR. Exogenous expression of the amino-terminal half of the tight junction protein ZO-3 perturbs junctional complex assembly. J Cell Biol 2000; 151:825-36. PMID:11076967 http://dx.doi.org/10.1083/jcb.151.4.825
52. Samak G, Narayanan D, Jaggar JH, Rao R. CaV1.3 channels and intracellular calcium mediate osmotic stress-induced N-terminal c-Jun kinase activation and disruption of tight junctions in Caco-2 CELL MONOLAYERS. J Biol Chem 2011; 286:30232-43. PMID:21737448 http://dx.doi.org/10.1074/jbc.M111.240358
53. Beutheu S, Ghouzali I, Galas L, Déchelotte P, Coëffier M. Glutamine and arginine improve permeability and tight junction protein expression in methotrexate-treated Caco-2 cells. Clin Nutr 2013; 32:863-9. PMID:23428392 http://dx.doi.org/10.1016/j.clnu.2013.01.014
54. Pinton P, Tsybulskyy D, Lucioli J, Laffitte J, Callu P, Lyazhri F, Grosjean F, Bracarense AP, Kolf-Clauw M, Oswald IP. Toxicity of deoxynivalenol and its acetylated derivatives on the intestine: differential effects on morphology, barrier function, tight junction proteins, and mitogen-activated protein kinases. Toxicol Sci 2012; 130:180-90. PMID:22859312 http://dx.doi.org/10.1093/toxsci/kfs239
55. Hu CH, Xiao K, Luan ZS, Song J. Early weaning increases intestinal permeability, alters expression of cytokine and tight junction protein, and activates mitogen-activated protein kinases in pigs. J Anim Sci 2012. PMID:23230104
56. Wang H, Zhao JX, Hu N, Ren J, Du M, Zhu MJ. Side-stream smoking reduces intestinal inflammation and increases expression of tight junction proteins. World J Gastroenterol 2012; 18:2180-7. PMID:22611310 http://dx.doi.org/10.3748/wjg. v18.i18.2180
57. ElAli A, Urrutia A, Rubio-Araiz A, Hernandez-Jimenez M, Colado MI, Doeppner TR, Hermann DM. Apolipoprotein-E controls adenosine triphosphate-binding cassette transporters ABCB1 and ABCC1 on cerebral microvessels after methamphetamine intoxication. Stroke 2012; 43:1647-53. PMID:22426312 http://dx.doi.org/10.1161/STROKEAHA.111.648923
58. Lampe PD, Lau AF. Regulation of gap junctions by phosphorylation of connexins. Arch Biochem Biophys 2000; 384:205-15. PMID:11368307 http://dx.doi.org/10.1006/abbi.2000.2131
59. Solan JL, Lampe PD. Connexin phosphorylation as a regulatory event linked to gap junction channel assembly. Biochim Biophys Acta 2005; 1711:154-63. PMID:15955300 http://dx.doi.org/10.1016/j. bbamem.2004.09.013
60. Norris RP, Freudzon M, Mehlmann LM, Cowan AE, Simon AM, Paul DL, Lampe PD, Jaffe LA. Luteinizing hormone causes MAP kinase-dependent phosphorylation and closure of connexin 43 gap junctions in mouse ovarian follicles: one of two paths to meiotic resumption. Development 2008; 135:3229-38. PMID:18776144 http://dx.doi.org/10.1242/dev.025494
61. Matesic DF, Sidorova TS, Burns TJ, Bell AM, Tran PL, Ruch RJ, May SW. p38 MAPK activation, JNK inhibition, neoplastic growth inhibition, and increased gap junction communication in human lung carcinoma and Ras-transformed cells by 4-phenyl-3-butenoic acid. J Cell Biochem 2012; 113:269-81. PMID:21898549 http://dx.doi.org/10.1002/jcb.23353
62. Ursitti JA, Petrich BG, Lee PC, Resneck WG, Ye X, Yang J, Randall WR, Bloch RJ, Wang Y. Role of an alternatively spliced form of alphaII-spectrin in localization of connexin 43 in cardiomyocytes and regulation by stress-activated protein kinase. J Mol Cell Cardiol 2007; 42:572-81. PMID:17276456 http://dx.doi.org/10.1016/j.yjmcc.2006.11.018
63. Humphries MJ. Integrin structure. Biochem Soc Trans 2000; 28:311-39. PMID:10961914 http://dx.doi.org/10.1042/0300-5127:0280311
64. Turner CE. Paxillin and focal adhesion signalling. Nat Cell Biol 2000; 2:E231-6. PMID:11146675 http://dx.doi.org/10.1038/35046659
65. Bouvard D, Pouwels J, De Franceschi N, Ivaska J. Integrin inactivators: balancing cellular functions in vitro and in vivo. Nat Rev Mol Cell Biol 2013; 14:430-42. PMID:23719537 http://dx.doi.org/10.1038/nrm3599
66. Poulos JE, Weber JD, Bellezzo JM, Di Bisceglie AM, Britton RS, Bacon BR, Baldassare JJ. Fibronectin and cytokines increase JNK, ERK, AP-1 activity, and transin gene expression in rat hepatic stellate cells. Am J Physiol 1997; 273:G804-11. PMID:9357821
67. Weston CA, Teressa G, Weeks BS, Prives J. Agrin and laminin induce acetylcholine receptor clustering by convergent, Rho GTPase-dependent signaling pathways. J Cell Sci 2007; 120:868-75. PMID:17298982 http://dx.doi.org/10.1242/jcs.03367
68. Jin YJ, Park I, Hong IK, Byun HJ, Choi J, Kim YM, Lee H. Fibronectin and vitronectin induce AP-1-mediated matrix metalloproteinase-9 expression through integrin α(5)β(1)/α(v)β(3)-dependent Akt, ERK and JNK signaling pathways in human umbilical vein endothelial cells. Cell Signal 2011; 23:125-34. PMID:20816750 http://dx.doi.org/10.1016/j. cellsig.2010.08.012
69. Chiu LH, Chen SC, Wu KC, Yang CB, Fang CL, Lai WF, Tsai YH. Differential effect of ECM molecules on re-expression of cartilaginous markers in near quiescent human chondrocytes. J Cell Physiol 2011; 226:1981-8. PMID:21520049 http://dx.doi.org/10.1002/jcp.22530
70. Jalali S, del Pozo MA, Chen K, Miao H, Li Y, Schwartz MA, Shyy JY, Chien S. Integrin-mediated mechanotransduction requires its dynamic interaction with specific extracellular matrix (ECM) ligands. Proc Natl Acad Sci U S A 2001; 98:1042-6. PMID:11158591 http://dx.doi.org/10.1073/pnas.98.3.1042
71. Katsumi A, Naoe T, Matsushita T, Kaibuchi K, Schwartz MA. Integrin activation and matrix binding mediate cellular responses to mechanical stretch. J Biol Chem 2005; 280:16546-9. PMID:15760908 http://dx.doi.org/10.1074/jbc.C400455200
72. Miyamoto S, Teramoto H, Coso OA, Gutkind JS, Burbelo PD, Akiyama SK, Yamada KM. Integrin function: molecular hierarchies of cytoskeletal and signaling molecules. J Cell Biol 1995; 131:791-805. PMID:7593197 http://dx.doi.org/10.1083/jcb.131.3.791
73. Li S, Kim M, Hu YL, Jalali S, Schlaepfer DD, Hunter T, Chien S, Shyy JY. Fluid shear stress activation of focal adhesion kinase. Linking to mitogen-activated protein kinases. J Biol Chem 1997; 272:30455-62. PMID:9374537 http://dx.doi.org/10.1074/jbc.272.48.30455
74. Huang C, Rajfur Z, Borchers C, Schaller MD, Jacobson K. JNK phosphorylates paxillin and regulates cell migration. Nature 2003; 424:219-23. PMID:12853963 http://dx.doi.org/10.1038/nature01745
75. Kimura K, Teranishi S, Yamauchi J, Nishida T. Role of JNK-dependent serine phosphorylation of paxillin in migration of corneal epithelial cells during wound closure. Invest Ophthalmol Vis Sci 2008; 49:125-32. PMID:18172084 http://dx.doi.org/10.1167/iovs.07-0725
76. Rosse C, Formstecher E, Boeckeler K, Zhao Y, Kremerskothen J, White MD, Camonis JH, Parker PJ. An aPKC-exocyst complex controls paxillin phosphorylation and migration through localised JNK1 activation. PLoS Biol 2009; 7:e1000235. PMID:19885391 http://dx.doi.org/10.1371/journal. pbio.1000235
77. Li JP, Fu YN, Chen YR, Tan TH. JNK pathway-associated phosphatase dephosphorylates focal adhesion kinase and suppresses cell migration. J Biol Chem 2010; 285:5472-8. PMID:20018849 http://dx.doi.org/10.1074/jbc.M109.060186
78. Kurosaka S, Kashina A. Cell biology of embryonic migration. Birth Defects Res C Embryo Today 2008; 84:102-22. PMID:18546335 http://dx.doi.org/10.1002/bdrc.20125
79. Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell 1996; 84:359-69. PMID:8608589 http://dx.doi.org/10.1016/S0092-8674(00)81280-5
80. Baum B, Georgiou M. Dynamics of adherens junctions in epithelial establishment, maintenance, and remodeling. J Cell Biol 2011; 192:907-17. PMID:21422226 http://dx.doi.org/10.1083/jcb.201009141
81. Huang C, Jacobson K, Schaller MD. A role for JNK-paxillin signaling in cell migration. Cell Cycle 2004; 3:4-6. PMID:14657652 http://dx.doi.org/10.4161/cc.3.1.601
82. Sluss HK, Han Z, Barrett T, Goberdhan DC, Wilson C, Davis RJ, Ip YT. A JNK signal transduction pathway that mediates morphogenesis and an immune response in Drosophila. Genes Dev 1996; 10:2745-58. PMID:8946915 http://dx.doi.org/10.1101/gad.10.21.2745
83. Riesgo-Escovar JR, Jenni M, Fritz A, Hafen E. The Drosophila Jun-N-terminal kinase is required for cell morphogenesis but not for DJun-dependent cell fate specification in the eye. Genes Dev 1996; 10:2759-68. PMID:8946916 http://dx.doi.org/10.1101/gad.10.21.2759
84. Xia Y, Makris C, Su B, Li E, Yang J, Nemerow GR, Karin M. MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration. Proc Natl Acad Sci U S A 2000; 97:5243-8. PMID:10805784 http://dx.doi.org/10.1073/pnas.97.10.5243
85. Yujiri T, Ware M, Widmann C, Oyer R, Russell D, Chan E, Zaitsu Y, Clarke P, Tyler K, Oka Y, et al. MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation. Proc Natl Acad Sci U S A 2000; 97:7272-7. PMID:10852963 http://dx.doi.org/10.1073/pnas.130176697
86. Zhang L, Wang W, Hayashi Y, Jester JV, Birk DE, Gao M, Liu CY, Kao WW, Karin M, Xia Y. A role for MEK kinase 1 in TGF-beta/activin-induced epithelium movement and embryonic eyelid closure. EMBO J 2003; 22:4443-54. PMID:12941696 http://dx.doi.org/10.1093/emboj/cdg440
87. Bosch M, Serras F, Martín-Blanco E, Baguñà J. JNK signaling pathway required for wound healing in regenerating Drosophila wing imaginal discs. Dev Biol 2005; 280:73-86. PMID:15766749 http://dx.doi.org/10.1016/j.ydbio.2005.01.002
88. Mattila J, Omelyanchuk L, Kyttälä S, Turunen H, Nokkala S. Role of Jun N-terminal Kinase (JNK) signaling in the wound healing and regeneration of a Drosophila melanogaster wing imaginal disc. Int J Dev Biol 2005; 49:391-9. PMID:15968584 http://dx.doi.org/10.1387/ijdb.052006jm
89. Lallemand D, Ham J, Garbay S, Bakiri L, Traincard F, Jeannequin O, Pfarr CM, Yaniv M. Stress-activated protein kinases are negatively regulated by cell density. EMBO J 1998; 17:5615-26. PMID:9755162 http://dx.doi.org/10.1093/emboj/17.19.5615
90. Zhang J, Dong J, Gu H, Yu S, Zhang X, Gou Y, Xu W, Burd A, Huang L, Miyado K, et al. CD9 is critical for cutaneous wound healing through JNK signaling. J Invest Dermatol 2012; 132:226-36. PMID:21881583 http://dx.doi.org/10.1038/jid.2011.268
91. Zhang M, Liu NY, Wang XE, Chen YH, Li QL, Lu KR, Sun L, Jia Q, Zhang L, Zhang L. Activin B promotes epithelial wound healing in vivo through RhoA-JNK signaling pathway. PLoS One 2011; 6:e25143. PMID:21949871 http://dx.doi.org/10.1371/journal.pone.0025143
92. Okada Y, Saika S, Shirai K, Yamanaka O, Kitano A, Wang Z, Yang H, Reinach P. JNK MAPK signaling contributes in vivo to injury-induced corneal epithelial migration. Ophthalmic Res 2009; 42:185-92. PMID:19672126 http://dx.doi.org/10.1159/000232401
93. Uchida C, Gee E, Ispanovic E, Haas TL. JNK as a positive regulator of angiogenic potential in endothelial cells. Cell Biol Int 2008; 32:769-76. PMID:18455449 http://dx.doi.org/10.1016/j. cellbi.2008.03.005
94. Shin EY, Kim SY, Kim EG. c-Jun N-terminal kinase is involved in motility of endothelial cell. Exp Mol Med 2001; 33:276-83. PMID:11795492 http://dx.doi.org/10.1038/emm.2001.45
95. Meadows KN, Bryant P, Vincent PA, Pumiglia KM. Activated Ras induces a proangiogenic phenotype in primary endothelial cells. Oncogene 2004; 23:192-200. PMID:14712224 http://dx.doi.org/10.1038/sj.onc.1206921
96. Rudrapatna VA, Bangi E, Cagan RLA. A Jnk-Rho-Actin remodeling positive feedback network directs Src-driven invasion. Oncogene 2013. PMID:23831567 http://dx.doi.org/10.1038/onc.2013.232
97. Ke H, Harris R, Coloff JL, Jin JY, Leshin B, Miliani de Marval P, Tao S, Rathmell JC, Hall RP, Zhang JY. The c-Jun NH2-terminal kinase 2 plays a dominant role in human epidermal neoplasia. Cancer Res 2010; 70:3080-8. PMID:20354187 http://dx.doi.org/10.1158/0008-5472.CAN-09-2923
98. Alexaki VI, Javelaud D, Mauviel A. JNK supports survival in melanoma cells by controlling cell cycle arrest and apoptosis. Pigment Cell Melanoma Res 2008; 21:429-38. PMID:18541008 http://dx.doi.org/10.1111/j.1755-148X.2008.00466.x
99. Potapova O, Gorospe M, Dougherty RH, Dean NM, Gaarde WA, Holbrook NJ. Inhibition of c-Jun N-terminal kinase 2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent manner. Mol Cell Biol 2000; 20:1713-22. PMID:10669748 http://dx.doi.org/10.1128/MCB.20.5.1713-1722.2000
100. Potapova O, Gorospe M, Bost F, Dean NM, Gaarde WA, Mercola D, Holbrook NJ. c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells. J Biol Chem 2000; 275:24767-75. PMID:10825181 http://dx.doi.org/10.1074/jbc.M904591199
101. Shibata W, Maeda S, Hikiba Y, Yanai A, Sakamoto K, Nakagawa H, Ogura K, Karin M, Omata M. c-Jun NH2-terminal kinase 1 is a critical regulator for the development of gastric cancer in mice. Cancer Res 2008; 68:5031-9. PMID:18593901 http://dx.doi.org/10.1158/0008-5472.CAN-07-6332
102. Vivanco I, Palaskas N, Tran C, Finn SP, Getz G, Kennedy NJ, Jiao J, Rose J, Xie W, Loda M, et al. Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN. Cancer Cell 2007; 11:555-69. PMID:17560336 http://dx.doi.org/10.1016/j.ccr.2007.04.021
103. Yang YM, Bost F, Charbono W, Dean N, McKay R, Rhim JS, Depatie C, Mercola D. C-Jun NH(2)-terminal kinase mediates proliferation and tumor growth of human prostate carcinoma. Clin Cancer Res 2003; 9:391-401. PMID:12538493
104. Wang Y, Dong Q, Miao Y, Fu L, Lin X, Wang E. Clinical significance and biological roles of SPAG9 overexpression in non-small cell lung cancer. Lung Cancer 2013; 81:266-72. PMID:23711689 http://dx.doi.org/10.1016/j.lungcan.2013.04.021
105. Gross ND, Boyle JO, Du B, Kekatpure VD, Lantowski A, Thaler HT, Weksler BB, Subbaramaiah K, Dannenberg AJ. Inhibition of Jun NH2-terminal kinases suppresses the growth of experimental head and neck squamous cell carcinoma. Clin Cancer Res 2007; 13:5910-7. PMID:17908987 http://dx.doi.org/10.1158/1078-0432.CCR-07-0352
106. Vivas-Mejia P, Benito JM, Fernandez A, Han HD, Mangala L, Rodriguez-Aguayo C, Chavez-Reyes A, Lin YG, Carey MS, Nick AM, et al. c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer. Clin Cancer Res 2010; 16:184-94. PMID:20028751 http://dx.doi.org/10.1158/1078-0432.CCR-09-1180
107. McCartney BM, Näthke IS. Cell regulation by the Apc protein Apc as master regulator of epithelia. Curr Opin Cell Biol 2008; 20:186-93. PMID:18359618 http://dx.doi.org/10.1016/j.ceb.2008.02.001
108. Salinas PC. Modulation of the microtubule cytoskeleton: a role for a divergent canonical Wnt pathway. Trends Cell Biol 2007; 17:333-42. PMID:17643305 http://dx.doi.org/10.1016/j.tcb.2007.07.003
109. Bryan RT, Tselepis C. Cadherin switching and bladder cancer. J Urol 2010; 184:423-31. PMID:20620393 http://dx.doi.org/10.1016/j.juro.2010.04.016
110. Berx G, van Roy F. Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol 2009; 1:a003129. PMID:20457567 http://dx.doi.org/10.1101/cshperspect.a003129
111. Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA, Isola JJ. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol 1996; 105:394-402. PMID:8604681
112. Qureshi HS, Linden MD, Divine G, Raju UB. E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters. Am J Clin Pathol 2006; 125:377-85. PMID:16613340
113. Sawada K, Mitra AK, Radjabi AR, Bhaskar V, Kistner EO, Tretiakova M, Jagadeeswaran S, Montag A, Becker A, Kenny HA, et al. Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target. Cancer Res 2008; 68:2329-39. PMID:18381440 http://dx.doi.org/10.1158/0008-5472.CAN-07-5167
114. Mimata A, Fukamachi H, Eishi Y, Yuasa Y. Loss of E-cadherin in mouse gastric epithelial cells induces signet ring-like cells, a possible precursor lesion of diffuse gastric cancer. Cancer Sci 2011; 102:942-50. PMID:21276134 http://dx.doi.org/10.1111/j.1349-7006.2011.01890.x
115. Fei Y, Liu X, Wang F, Wang W, Liu S. E-cadherin Expression in Normal and Abnormal Tissue Specimens From Patients With Pancreatic Carcinoma. LabMedicine 2010; 41:473-7
116. Strumane K, Berx G, Van Roy F. Cadherins in cancer. Handb Exp Pharmacol 2004; 69-103. PMID:20455091 http://dx.doi.org/10.1007/978-3-540-68170-0_4
117. Perez-Moreno M, Fuchs E. Catenins: keeping cells from getting their signals crossed. Dev Cell 2006; 11:601-12. PMID:17084354 http://dx.doi.org/10.1016/j.devcel.2006.10.010
118. Kobielak A, Fuchs E. Links between alpha-catenin, NF-kappaB, and squamous cell carcinoma in skin. Proc Natl Acad Sci U S A 2006; 103:2322-7. PMID:16452166 http://dx.doi.org/10.1073/pnas.0510422103
119. Larue L, Ohsugi M, Hirchenhain J, Kemler R. E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proc Natl Acad Sci U S A 1994; 91:8263-7. PMID:8058792 http://dx.doi.org/10.1073/pnas.91.17.8263
120. Torres M, Stoykova A, Huber O, Chowdhury K, Bonaldo P, Mansouri A, Butz S, Kemler R, Gruss P. An alpha-E-catenin gene trap mutation defines its function in preimplantation development. Proc Natl Acad Sci U S A 1997; 94:901-6. PMID:9023354 http://dx.doi.org/10.1073/pnas.94.3.901
121. Vasioukhin V, Bauer C, Degenstein L, Wise B, Fuchs E. Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin. Cell 2001; 104:605-17. PMID:11239416 http://dx.doi.org/10.1016/S0092-8674(01)00246-X
122. Brumby AM, Richardson HE. scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in Drosophila. EMBO J 2003; 22:5769-79. PMID:14592975 http://dx.doi.org/10.1093/emboj/cdg548
123. Pagliarini RA, Xu T. A genetic screen in Drosophila for metastatic behavior. Science 2003; 302:1227-31. PMID:14551319 http://dx.doi.org/10.1126/science.1088474
124. Dow LE, Elsum IA, King CL, Kinross KM, Richardson HE, Humbert PO. Loss of human Scribble cooperates with H-Ras to promote cell invasion through deregulation of MAPK signalling. Oncogene 2008; 27:5988-6001. PMID:18641685 http://dx.doi.org/10.1038/onc.2008.219
125. Shintani Y, Hollingsworth MA, Wheelock MJ, Johnson KR. Collagen I promotes metastasis in pancreatic cancer by activating c-Jun NH(2)-terminal kinase 1 and up-regulating N-cadherin expression. Cancer Res 2006; 66:11745-53. PMID:17178870 http://dx.doi.org/10.1158/0008-5472.CAN-06-2322
126. Foldynová-Trantírková S, Sekyrová P, Tmejová K, Brumovská E, Bernatík O, Blankenfeldt W, Krejcí P, Kozubík A, Dolezal T, Trantírek L, et al. Breast cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration. Breast Cancer Res 2010; 12:R30. PMID:20507565 http://dx.doi.org/10.1186/bcr2581